Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis - A Prospective Double-blind Placebo-controlled Trial
Conditions: Infertility; Endometriosis Interventions: Drug: Elagolix 200 MG; Drug: Placebo Sponsors: Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of Colorado, Denver; Northwestern University; University of North Carolina Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Child Development | Children | Endometriosis | Infertility | Reproduction Medicine | Research | Women